How are hsCRP and gut health related?

The relationship between hsCRP (high-sensitivity C-reactive protein) and gut health is an area of active research but remains incompletely understood. HsCRP is a systemic marker of inflammation, while gut health encompasses microbiome composition, intestinal barrier integrity, and local immune function. Mechanistically, a compromised gut barrier can allow bacterial endotoxins (e.g., lipopolysaccharides) to enter the bloodstream, triggering an inflammatory response that elevates hsCRP. Additionally, gut dysbiosis—an imbalance in microbial communities—has been associated with low-grade systemic inflammation and higher hsCRP levels in observational studies. However, the evidence is largely associative and mechanistic; robust human intervention trials directly linking gut health modulation to hsCRP changes are limited. Consumer tests like those from MyBody-X that measure hsCRP or gut markers are not diagnostic and cannot establish causality. An elevated hsCRP should prompt medical evaluation for underlying conditions such as cardiovascular disease or chronic infection. Gut health is multifactorial, and no single biomarker can capture its complexity. Therefore, while a link exists, it should not be oversimplified by direct-to-consumer tests.